Two new treatments for AF that returned after first procedure
Part of Heart & circulation clinical trials.
This trial tests two new treatments for persistent atrial fibrillation that came back after an initial procedure. One uses a targeted chemical injection, the other uses a special energy field to re-isolate the veins involved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that lasts 7 days or more and causes symptoms.
- You have already had a pulmonary vein isolation (PVI) procedure that didn't work.
- Your atrial fibrillation has not been going on continuously for a year or more.
- You do not have advanced heart valve disease, a very large left atrium, or other major health problems.
- You weigh less than 150 kg (about 330 lbs) and are otherwise eligible for catheter ablation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, possibly safer way to treat persistent atrial fibrillation using pulsed field ablation. It compares standard vein isolation alone to adding extra ablation spots to improve success.
This trial tests whether adding extra ablation lines to the standard pulmonary vein isolation procedure is more effective for people with persistent atrial fibrillation that hasn't been helped by medications. The goal is to improve symptoms like palpitations, fatigue, and shortness of breath.
This trial tests a more precise way to burn (ablate) the back wall of the left upper heart chamber during the first ablation for persistent atrial fibrillation (AF). It aims to improve heart rhythm control and reduce the chance of AF coming back.
This study tests a new heart procedure using pulsed field ablation (a type of energy to fix irregular heartbeats) for people who have had atrial fibrillation for less than a year. It may help restore a normal heart rhythm and reduce symptoms.
This trial compares two ways to treat persistent atrial fibrillation (an irregular heartbeat that lasts for months or years). One method uses pulsed field energy and the other uses radiofrequency heat to fix the heart's electrical signals. The goal is to see which method is safer and more effective for patients having their first ablation procedure.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.